Douglas R. Fullen

Associate Professor, Departments of Pathology and Dermatology

Selected Publications

1. Fullen DR, Headington JT: Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical-growth phase melanomas. J Cutan Pathol 553-558, 1998.
2. Fullen DR, Reed JA, Finnerty BF, McNutt NS: S100 A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for Schwannian differentiation of intradermal nevi. J Cutan Pathol 28: 393-399, 2001.
3. Murphy M, Fullen D, Carlson JA: Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue. Am J Dermatopathol 24: 6-16, 2002.
4. Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L: Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer 97: 499-507, 2003.
5. Fullen DR, Lowe L, Su LD: Antibody to S100 A6 is a sensitive immunohistochemical marker for neurothekeoma. J Cutan Pathol 30: 118-112, 2003.
6. Bogner PN, Fullen DR, Lowe L, Paulino A, Biermann JS, Sondak VK, Su LD: Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer 97: 2285-2289, 2003.
7. Su LD, Fullen DR, Lowe L, Wang TS, Schwartz JL, Cimmino VM, Sondak VK, Johnson TM: Desmoplastic and neurotropic melanoma. Cancer 100: 598-604, 2004.
8. Karimipour DF, Lowe L, Su L, Hamilton T, Sondak V, Johnson TM, Fullen D: Standard immunostains for melanoma in sentinel lymph node specimens: Which ones are most useful? J Am Acad Dermatol 50: 759-764, 2004.
9. Bogner PN, Su LD, Fullen DR: Cluster Designation 5 (CD5) staining of normal and non-lymphoid neoplastic skin. J Cutan Pathol 32:50-54, 2005.
10. Fullen DR, Zhu W, Thomas D, Su LD: HTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissues. J Cutan Pathol 32: 680-684, 2005.